• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与心脏传导缺陷之间的关联。

Association between obesity and cardiac conduction defects.

作者信息

Mostafa Mohamed A, Kingsley Jeff A, Soliman Elsayed Z, Bhave Prashant D

机构信息

Department of Cardiovascular medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.

出版信息

Front Cardiovasc Med. 2025 Jul 9;12:1476935. doi: 10.3389/fcvm.2025.1476935. eCollection 2025.

DOI:10.3389/fcvm.2025.1476935
PMID:40703631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12284001/
Abstract

BACKGROUND

Literature on the association between high body mass index (BMI) and cardiac conduction defects (CCD) is scarce.

METHODS

The cross-sectional association between obesity and CCD was examined in 455,790 participants (56.1 years; 55.9% females) from the United Kingdom (UK) Biobank. CCD was defined by ICD codes as the presence of either atrioventricular block (AVB) or intraventricular block (IVB). Multivariable logistic regression models were used to assess the association between different levels of BMI and CCD.

RESULTS

About 2.7% ( = 12,169) of the participants exhibited CCD. Each 1-SD increase in BMI (4.68 kg/m) was associated with increased odds of CCD (OR (95% CI): 1.03 (1.01, 1.06). In subgroup analysis, this association was stronger in older participants (>65 vs. <65 years), men than women, and participants with diabetes (interaction -value < 0.05 for all). In a stratified analysis by CCD subtypes, each 1-SD of BMI was associated with increased odds of AVB, but not IVB [OR (95% CI): 1.04 (1.01, 1.07), 0.97 (0.89, 1.05), respectively]. Compared to normal BMI (25-29.9 Kg/m), participants with marked obesity, defined as BMI >40 Kg/m, had 20% increased odds of CCD (OR (95% CI): 1.20 (1.04, 1.39). No significant association was observed with BMI between 30 and 39.9 Kg/m.

CONCLUSIONS

Higher BMI levels are associated with an increased risk of CCD, which is probably triggered by AVB, and the association is stronger in men, the elderly, and those with diabetes; further research is needed to examine whether weight management in obesity will be accompanied by a reduction in the risk of CCD.

摘要

背景

关于高体重指数(BMI)与心脏传导缺陷(CCD)之间关联的文献较少。

方法

在来自英国生物银行的455,790名参与者(年龄56.1岁;女性占55.9%)中研究肥胖与CCD之间的横断面关联。CCD通过国际疾病分类代码定义为存在房室传导阻滞(AVB)或室内传导阻滞(IVB)。使用多变量逻辑回归模型评估不同BMI水平与CCD之间的关联。

结果

约2.7%(n = 12,169)的参与者表现出CCD。BMI每增加1个标准差(4.68 kg/m²)与CCD发生几率增加相关(比值比(95%置信区间):1.03(1.01,1.06))。在亚组分析中,这种关联在老年参与者(>65岁与<65岁)、男性中比女性更强,以及在糖尿病患者中更强(所有交互P值<0.05)。在按CCD亚型进行的分层分析中,BMI每增加1个标准差与AVB发生几率增加相关,但与IVB无关[比值比(95%置信区间)分别为1.04(1.01,1.07),0.97(0.89,1.05)]。与正常BMI(25 - 29.9 Kg/m²)相比,定义为BMI>40 Kg/m²的显著肥胖参与者患CCD的几率增加20%(比值比(95%置信区间):1.20(1.04,1.39))。在30至39.9 Kg/m²的BMI之间未观察到显著关联。

结论

较高的BMI水平与CCD风险增加相关,这可能由AVB引发,并且这种关联在男性、老年人和糖尿病患者中更强;需要进一步研究以检查肥胖症患者的体重管理是否会伴随着CCD风险的降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/307d/12284001/eba7f103df76/fcvm-12-1476935-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/307d/12284001/eba7f103df76/fcvm-12-1476935-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/307d/12284001/eba7f103df76/fcvm-12-1476935-g001.jpg

相似文献

1
Association between obesity and cardiac conduction defects.肥胖与心脏传导缺陷之间的关联。
Front Cardiovasc Med. 2025 Jul 9;12:1476935. doi: 10.3389/fcvm.2025.1476935. eCollection 2025.
2
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study.肥胖症患者下肢关节置换术后发生肺栓塞或近端下肢深静脉血栓的风险是否增加?一项大数据库研究。
Clin Orthop Relat Res. 2024 Jan 1;482(1):115-124. doi: 10.1097/CORR.0000000000002742. Epub 2023 Jul 4.
4
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people.老年人即将发生和当前失水脱水的识别的临床症状、体征及检查
Cochrane Database Syst Rev. 2015 Apr 30;2015(4):CD009647. doi: 10.1002/14651858.CD009647.pub2.
5
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
6
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
7
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
8
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.

本文引用的文献

1
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy.替尔泊肽可减轻肥胖相关心力衰竭患者的左心室质量和心周脂肪组织:SUMMIT CMR 子研究
J Am Coll Cardiol. 2025 Feb 25;85(7):699-706. doi: 10.1016/j.jacc.2024.11.001. Epub 2024 Nov 18.
2
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.替尔泊肽用于射血分数保留的心力衰竭合并肥胖症
N Engl J Med. 2025 Jan 30;392(5):427-437. doi: 10.1056/NEJMoa2410027. Epub 2024 Nov 16.
3
The weight reduction mediated by anti-obesity medication and the cardiovascular outcome.
抗肥胖药物介导的体重减轻与心血管结局。
iScience. 2024 Sep 5;27(10):110867. doi: 10.1016/j.isci.2024.110867. eCollection 2024 Oct 18.
4
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.司美格鲁肽对肥胖相关性心力衰竭患者心脏结构和功能的影响。
J Am Coll Cardiol. 2024 Oct 22;84(17):1587-1602. doi: 10.1016/j.jacc.2024.08.021. Epub 2024 Aug 30.
5
The association between weight loss medications and cardiovascular complications.减肥药物与心血管并发症的关联。
Obesity (Silver Spring). 2024 Jul;32(7):1401-1409. doi: 10.1002/oby.24037. Epub 2024 May 6.
6
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
7
Obesity and Cardiac Conduction Block Disease in China.中国肥胖与心脏传导阻滞疾病。
JAMA Netw Open. 2023 Nov 1;6(11):e2342831. doi: 10.1001/jamanetworkopen.2023.42831.
8
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.司美格鲁肽治疗射血分数保留的心力衰竭合并肥胖患者的疗效。
N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25.
9
Association Between Intensive vs Standard Blood Pressure Control and Incident Left Ventricular Conduction Disease: A Post Hoc Analysis of the SPRINT Randomized Clinical Trial.强化与标准血压控制与新发左束支传导阻滞相关性的研究:SPRINT 随机临床试验的事后分析。
JAMA Cardiol. 2023 Jun 1;8(6):612-616. doi: 10.1001/jamacardio.2023.0845.
10
Lifestyle habits associated with cardiac conduction disease.与心脏传导疾病相关的生活习惯。
Eur Heart J. 2023 Mar 21;44(12):1058-1066. doi: 10.1093/eurheartj/ehac799.